141 related articles for article (PubMed ID: 10878734)
1. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.
Weiner SM; Otte A; Schumacher M; Brink I; Juengling FD; Sobanksi T; Nitzsche EU; Peter HH
Lupus; 2000; 9(5):386-9. PubMed ID: 10878734
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study.
Otte A; Weiner SM; Hoegerle S; Wolf R; Juengling FD; Peter HH; Nitzsche EU
Lupus; 1998; 7(1):57-9. PubMed ID: 9493152
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.
Lee SW; Park MC; Lee SK; Park YB
Lupus; 2012 Dec; 21(14):1531-7. PubMed ID: 22941565
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
5. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.
Weiner SM; Otte A; Schumacher M; Klein R; Gutfleisch J; Brink I; Otto P; Nitzsche EU; Moser E; Peter HH
Ann Rheum Dis; 2000 May; 59(5):377-85. PubMed ID: 10784521
[TBL] [Abstract][Full Text] [Related]
7. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
[TBL] [Abstract][Full Text] [Related]
8. Glucose Hypermetabolism in Contralateral Basal Ganglia Demonstrated by Serial FDG PET/CT Scans in a Patient With SLE Chorea.
Niu N; Cui R
Clin Nucl Med; 2017 Jan; 42(1):64-65. PubMed ID: 27819860
[TBL] [Abstract][Full Text] [Related]
9. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
Saito T; Tamura M; Chiba Y; Katsuse O; Suda A; Kamada A; Ikura T; Abe K; Ogawa M; Minegishi K; Yoshimi R; Kirino Y; Ihata A; Hirayasu Y
J Neurol Sci; 2017 Aug; 379():127-130. PubMed ID: 28716225
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations.
Sanna G; Piga M; Terryberry JW; Peltz MT; Giagheddu S; Satta L; Ahmed A; Cauli A; Montaldo C; Passiu G; Peter JB; Shoenfeld Y; Mathieu A
Lupus; 2000; 9(8):573-83. PubMed ID: 11035431
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
Al-Obaidi M; Saunders D; Brown S; Ramsden L; Martin N; Moraitis E; Pilkington CA; Brogan PA; Eleftheriou D
Clin Rheumatol; 2016 Oct; 35(10):2449-56. PubMed ID: 27527090
[TBL] [Abstract][Full Text] [Related]
13. [A central nervous system lupus showing peculiar findings on cranial magnetic resonance imaging (MRI)].
Takahashi T; Kokubun Y; Okuhata Y; Sawada S; Mizutani T
Rinsho Shinkeigaku; 2003 Jul; 43(7):409-16. PubMed ID: 14582367
[TBL] [Abstract][Full Text] [Related]
14. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.
Abreu MR; Jakosky A; Folgerini M; Brenol JC; Xavier RM; Kapczinsky F
Clin Imaging; 2005; 29(3):215-21. PubMed ID: 15855069
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.
Sailer M; Burchert W; Ehrenheim C; Smid HG; Haas J; Wildhagen K; Wurster U; Deicher H
J Neurol; 1997 Mar; 244(3):186-93. PubMed ID: 9050960
[TBL] [Abstract][Full Text] [Related]
17. Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.
Mackay M; Tang CC; Volpe BT; Aranow C; Mattis PJ; Korff RA; Diamond B; Eidelberg D
Lupus Sci Med; 2015; 2(1):e000074. PubMed ID: 25861456
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
[TBL] [Abstract][Full Text] [Related]
19. PET/CT imaging in systemic lupus erythematosus.
Curiel R; Akin EA; Beaulieu G; DePalma L; Hashefi M
Ann N Y Acad Sci; 2011 Jun; 1228():71-80. PubMed ID: 21718325
[TBL] [Abstract][Full Text] [Related]
20. Metabolic changes of subcortical structures in intractable focal epilepsy.
Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
